Vista Pharmaceuticals has informed that the meeting of Board of directors of the company which was scheduled to be held on 29.11.2017 at 4.30 pm has been rescheduled to 28.11.2017 at 4.30 pm. at the corporate office of the company to consider the allotment of convertible warrants to the promoters and others on preferential basis.
The above information is a part of company’s filings submitted to BSE.